Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Zosano Pharma Corporation (ZSAN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.6342-0.0074 (-1.15%)
At close: 4:00PM EDT
0.6400 +0.01 (+0.91%)
After hours: 07:54PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 3.62
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.0600
52 Week Low 30.3280
50-Day Moving Average 30.6902
200-Day Moving Average 30.8189

Share Statistics

Avg Vol (3 month) 3996.31k
Avg Vol (10 day) 3639.26k
Shares Outstanding 5106.73M
Implied Shares Outstanding 6N/A
Float 8114.94M
% Held by Insiders 10.36%
% Held by Institutions 114.40%
Shares Short (Aug 12, 2021) 46.58M
Short Ratio (Aug 12, 2021) 46.55
Short % of Float (Aug 12, 2021) 45.84%
Short % of Shares Outstanding (Aug 12, 2021) 45.69%
Shares Short (prior month Jul 14, 2021) 47.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 25, 2018
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 25, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-4,848.36%

Management Effectiveness

Return on Assets (ttm)-37.40%
Return on Equity (ttm)-101.00%

Income Statement

Revenue (ttm)670k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-21.57M
EBITDA -30.71M
Net Income Avi to Common (ttm)-31.07M
Diluted EPS (ttm)-0.3860
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)22.06M
Total Cash Per Share (mrq)0.19
Total Debt (mrq)12.46M
Total Debt/Equity (mrq)28.94
Current Ratio (mrq)2.09
Book Value Per Share (mrq)0.41

Cash Flow Statement

Operating Cash Flow (ttm)-30.72M
Levered Free Cash Flow (ttm)-31.63M
Advertisement
Advertisement